Listed by the USPTO as KOSTURKO, GEORGE W
Tech Center 1600 • Art Units: 1621 1627 1628
This examiner grants 55% of resolved cases
KOSTURKO, GEORGE W serves in tech center 1600 and art unit 1621. The profile records 735 resolved cases, an allowance rate of 54.6%, and a median of 995 days to allowance. Its interview lift is 49.0%, indicating that cases associated with interviews had a higher allowance outcome than the overall record.
Hoffmann-La Roche Inc., Boehringer Ingelheim International GmbH, and Hk Inno N Corporation are the listed companies. The firms appearing most often are The Roy Gross Law Firm, LLC, DERGOSITS & NOAH LLP, and Giordano Law LLC. The gap between the allowance rate and the positive interview-associated outcome makes interview preparation particularly relevant to prosecution strategy. Practitioners should use that setting to identify the examiner’s central distinctions and test potential claim amendments, while documenting the resulting positions in writing. The median timing supports planning for continued prosecution rather than assuming rapid resolution.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18702989 | CRYSTALLINE FORMS OF QUINAZOLINE DERIVATIVES, PREPARATION, COMPOSITION AND USE THEREOF | Non-Final OA | Hoffmann-La Roche Inc. |
| 18271102 | METHODS FOR PREVENTING OR TREATING CONDITIONS RELATED TO T CELL MEDIATED INTESTINAL DISORDERS | Final Rejection | The Regents of the University of Michigan |
| 18800173 | CARDIO- AND RENOSAFE ANTIDIABETIC THERAPY | Non-Final OA | Boehringer Ingelheim International GmbH |
| 18817828 | TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING AN ATP COMPETITIVE AKT INHIBITOR, A CDK4/6 INHIBITOR, AND FULVESTRANT | Non-Final OA | Genentech, Inc. |
| 18755253 | TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS | Non-Final OA | Sun Pharmaceutical Industries, Inc. |
| 18554927 | USE OF GOSSYPOL AND A METHANE INHIBITOR FOR REDUCING THE FORMATION OF METHANE EMANATING FROM THE DIGESTIVE ACTIVITIES OF RUMINANTS | Non-Final OA | DSM IP ASSETS B.V. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy54.6% of resolved applications examined by George W Kosturko were allowed (735 resolved cases), compared with 46.0% across Art Unit 1621 over the last five years.
This examiner's interview lift is +49.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by George W Kosturko took 995 days on average from filing to allowance.
George W Kosturko examines applications in Art Unit 1621 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
